|
Volumn 31, Issue 2, 2001, Pages 133-141
|
Cotrimoxazole treatment for rheumatoid arthritis
a a a a |
Author keywords
Autoimmune diseases; Cotrimoxazole; Rheumatoid arthritis; Sulfamethoxazole; Trimethoprim
|
Indexed keywords
C PEPTIDE;
CORTICOSTEROID;
COTRIMOXAZOLE;
CYTOKINE;
DAPSONE;
DIHYDROFOLATE REDUCTASE;
DIHYDROPTEROATE SYNTHASE;
DNA;
GOLD;
HALIDE;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LEFLUNOMIDE;
METHOTREXATE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXIDE;
PLASMA PROTEIN;
SULFAPYRIDINE;
SULFONAMIDE;
SUPEROXIDE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
HUMAN;
HYPOGLYCEMIA;
IMMUNOMODULATION;
NAUSEA AND VOMITING;
NONHUMAN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
|
EID: 0034770435
PISSN: 00490172
EISSN: None
Source Type: Journal
DOI: 10.1053/sarh.2001.27734 Document Type: Article |
Times cited : (22)
|
References (63)
|